Related Experiment Video
Updated: Jun 16, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?
Francesco Castelli1, Virginio Pietra, Ismael Diallo
1University of Brescia, Italy; CLIA - Network for International Fight against AIDS; President, Medicus Mundi Italy.
Abstract:
Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including () cost of care for the individual, () stigma, () lack of qualified human resources and infrastructure, especially in the rural setting, () rescue drugs for failing patients and () pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include: (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users' fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Therapeutic Drug Monitoring: Affecting Factors
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Treatment Resistent Cancers

